The Safety of Performing Bloodless Autologous Stem Cell Transplantation in Jehovah's Witness Patients.

Due to the curative potential and improvement in progression-free survival (PFS), high dose chemotherapy followed by autologous stem cell transplantation (ASCT) is considered the standard of care for several hematologic malignancies such as multiple myeloma, and lymphomas in different treatment stages. However, the process of ASCT typically involves support with blood product transfusion until neutrophil and platelet engraftment occurs. Thus, difficulties arise when ASCT is indicated for Jehovah's witness patients - a religious group known for refusing blood products.
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Tags: 547 Source Type: research